| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/01/2004 | US20040063975 Antiinflammatory agents; antiischemic agents; central nervous system disorders; prevent tissue degradation |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063954 Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites |
| 04/01/2004 | US20040063940 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 04/01/2004 | US20040063937 Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives |
| 04/01/2004 | US20040063936 Pyrimidine derivatives and process for preparing the same |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063775 Five-membered heterocyclic alkanoic acid derivative |
| 04/01/2004 | US20040063772 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-pyrazolecarboxylic acid, 1-(4-fluoro-3-cyanophenyl)-3-trifluoromethyl-5-(2-furyl)pyrazole, and imidazole |
| 04/01/2004 | US20040063763 2-methoxyimino-2(pyridinyloxymethyl)phenyl acetamides useful as fungicides |
| 04/01/2004 | US20040063762 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 04/01/2004 | US20040063756 Administering a therapeutically effective amount of 2-Aminoquinolines for the prevention or treatment of eating disorders, weight gain and obesity |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063746 For treatment of HIV |
| 04/01/2004 | US20040063744 Such as 1-(4-(1-bromo-1-phenyl-methylene)-piperidin-1-yl)-2-(4,7-dimethoxy-6 -azaindol-3-yl)-ethane-1,2-dione for treatment of HIV and acquired immune deficiency syndrome |
| 04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
| 04/01/2004 | US20040063720 Tyrosine kinase inhibitors |
| 04/01/2004 | US20040063705 Substituted pyrimidinyl derivatives and methods of use |
| 04/01/2004 | US20040063704 Central nervous system disorders including depression and/or anxiety; 5-HT1 type receptor and/or serotonin reuptake inhibition activity |
| 04/01/2004 | US20040063700 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 04/01/2004 | US20040063693 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 04/01/2004 | US20040063691 Preparation and use of imidazole derivatives for treatment of obesity |
| 04/01/2004 | US20040063690 Cardiovascular disorders; guanylate cyclase activation; diseases associated with disturbed cyclic guanosine monophosphate balance |
| 04/01/2004 | US20040063673 Specific MMP-13 enzyme inhibitors; tissue breakdown diseases |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063665 Anticancer agents; high degree of discrimination toward malignant cells; reducing side effects; nontoxic; such as 3-chloro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040062713 Dye; photosensitive stimulant; using eye |
| 04/01/2004 | DE10243939A1 Pyrroline Pyrrolines |
| 04/01/2004 | CA2499964A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | CA2499332A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | CA2499326A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | CA2498781A1 Indolinones substituted by heterocycles, their preparation thereof and their use as medicaments |
| 04/01/2004 | CA2497971A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | CA2497560A1 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 03/31/2004 | EP1403269A1 Remedial agent for viral infectious disease |
| 03/31/2004 | EP1403268A1 Fluorescent probes for zinc |
| 03/31/2004 | EP1403253A1 Novel heterocyclic compound and medicinal use thereof |
| 03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
| 03/31/2004 | EP1401834A1 New derivatives of oxazolidinones as antibacterial agents |
| 03/31/2004 | EP1401831A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
| 03/31/2004 | EP1401830A2 Quinazolinediones as antibacterial agents |
| 03/31/2004 | EP1401817A1 Isoquinoline compounds having antiinfective activity |
| 03/31/2004 | EP1401443A1 Novel anti-infectives |
| 03/31/2004 | EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 03/31/2004 | EP1401433A2 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 03/31/2004 | EP1401351A2 Method for treating glaucoma vi |
| 03/31/2004 | EP1370258A4 Peptide deformylase inhibitors |
| 03/31/2004 | EP1240163B1 3-(4,5-dihydroisoxazole-5-yl)benzoylpyrazole |
| 03/31/2004 | EP1181294B1 Novel derivatives and analogues of galanthamin |
| 03/31/2004 | EP1095040B1 New benzoxazoles with pde-inhibiting activity |
| 03/31/2004 | EP0901470B1 Indole derivatives useful as endothelin receptor antagonists |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 03/31/2004 | CN1143857C Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 03/31/2004 | CN1143855C I (ortho)-anthranilamide derivatives as anti-coagulants |
| 03/31/2004 | CN1143849C Pyridine ketones used as herbicides |
| 03/31/2004 | CN1143848C 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists |
| 03/31/2004 | CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 03/30/2004 | US6713651 β2-adrenergic receptor agonists |
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 03/30/2004 | US6713508 Such as 7-(3-(3-trifluoromethyl-7-propyl-6-benz-(4,5)-isoxazoloxy)propoxy)-2 -ethylchromane-2-carboxylic acid which are potent agonists of peroxisome proliferator activated receptor |
| 03/30/2004 | US6713498 Method for treating glaucoma VI |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713482 Such as (e)-1-(2-pyridyl)-2-styryl-1h-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 03/30/2004 | US6713478 Cyclocarbamate derivatives as progesterone receptor modulators |
| 03/30/2004 | US6713473 6-carbamate-1,2,3,4-tetrahydrocarbazole derivatives; affinity for neuropeptide y receptors |
| 03/30/2004 | US6713472 Thiazine or pyrazine derivatives |
| 03/30/2004 | US6713436 1-cycloalkylpyrazolyl-benzoyl derivatives |
| 03/25/2004 | WO2004024939A2 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 03/25/2004 | WO2004024726A1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes |
| 03/25/2004 | WO2004024725A1 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole derivatives and the use of the same as antidepressants |
| 03/25/2004 | WO2004024701A1 Heterocyclic derivatives |
| 03/25/2004 | WO2004024700A1 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 03/25/2004 | WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 03/25/2004 | WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease |
| 03/25/2004 | WO2004024159A1 INHIBITORS OF TFGβ |
| 03/25/2004 | WO2004024140A1 Efflux pump inhibitors |
| 03/25/2004 | WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/25/2004 | WO2004000808A3 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/25/2004 | WO2004000214A3 Use of compounds having an amine nucleus in manufacture of a medicament useful for treating factor viia-associated conditions |
| 03/25/2004 | WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis |
| 03/25/2004 | WO2003082186A3 Use of benzimidazole analogs in the treatment of cell proliferation |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | US20040059138 Dihydropyrancarboxamides and uses thereof |
| 03/25/2004 | US20040059123 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 03/25/2004 | US20040059120 Such as (5R)-3-(3-fluoro-4-(2-oxo-1,3-oxazolan-3-yl)phenyl)-5-hydroxymethyl-1,3 -oxazolan-2-one |
| 03/25/2004 | US20040059116 Aryl aniline beta2 adrenergic receptor agonists |
| 03/25/2004 | US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents |
| 03/25/2004 | US20040058965 Alkanoic acid derivatives process for their production and use thereof |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases |
| 03/25/2004 | US20040058960 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/25/2004 | US20040058956 Oral absorption; bioavailability of antiproliferative agent |
| 03/25/2004 | US20040058934 Heterocyclic compounds |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |